Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Apr;54(2):152-62.

The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum

The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum

S Leibowitz et al. Br J Exp Pathol. 1973 Apr.

Abstract

Tuberculin (PPD) injected into the pleural cavity of sensitized guinea-pigs results in the development of a large protein-rich effusion over a period of 24 hours. In the early stages the effusion contains large numbers of polymorphonuclear leucocytes, but later mononuclear cells (lymphocytes and monocytes) predominate. At 24 hours a small percentage of the lymphocytes have the character of lymphoid blast cells, while some of the monocytes contain phagocytosed polymorphonuclear cells or nuclear debris.

A similar phenomenon can be elicited in mice sensitized with complete Freund's adjuvant. However, in these animals the volume of the effusion is small and difficult to measure accurately.

The effusion in the guinea-pig is completely suppressed by antilymphocyte serum (ALS). This effect is relatively long lasting (compared with its transient action on a nonspecific inflammatory lesion due to turpentine) and recovery parallels the return of the tuberculin reaction in the skin—providing further confirmation that the effusion is due to delayed hypersensitivity.

The tuberculin PPD reaction in the pleural cavity provides a useful model of delayed hypersensitivity in which exudate and viable inflammatory cells can be collected for study during the development of the lesion.

PubMed Disclaimer

References

    1. Am J Pathol. 1967 Mar;50(3):485-521 - PubMed
    1. Lab Invest. 1967 Sep;17(3):334-49 - PubMed
    1. J Immunol. 1968 Sep;101(3):481-7 - PubMed
    1. Clin Exp Immunol. 1968 Oct;3(8):753-60 - PubMed
    1. J Pathol. 1969 Feb;97(2):295-305 - PubMed

MeSH terms

LinkOut - more resources